These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 28950820)

  • 21. Unmet technological demands in orodispersible films for age-appropriate paediatric drug delivery.
    Chacko IA; Ramachandran G; Sudheesh MS
    Drug Deliv Transl Res; 2024 Apr; 14(4):841-857. PubMed ID: 37957474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of Natural Gums and Mucilages as Pharmaceutical Excipients.
    Hamman H; Steenekamp J; Hamman J
    Curr Pharm Des; 2015; 21(33):4775-97. PubMed ID: 26290212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug Formulations: Standards and Novel Strategies for Drug Administration in Pediatrics.
    Thabet Y; Klingmann V; Breitkreutz J
    J Clin Pharmacol; 2018 Oct; 58 Suppl 10():S26-S35. PubMed ID: 30248193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmaceutical Excipient Exposure in a Neonatal Intensive Care Unit.
    Nasrollahi S; Meera NK; Boregowda S
    Indian Pediatr; 2020 Sep; 57(9):801-804. PubMed ID: 32999107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Excipients with specialized functions for effective drug delivery.
    Hamman J; Steenekamp J
    Expert Opin Drug Deliv; 2012 Feb; 9(2):219-30. PubMed ID: 22196483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overview of solidification techniques for self-emulsifying drug delivery systems from industrial perspective.
    Mandić J; Zvonar Pobirk A; Vrečer F; Gašperlin M
    Int J Pharm; 2017 Nov; 533(2):335-345. PubMed ID: 28528850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Availability of age-appropriate paediatric formulations in the Netherlands: the need in daily clinical practice remains.
    van der Vossen A; Buljaç S; Akçay K; Brugma JD; Vulto A; Hanff L
    Eur J Hosp Pharm; 2021 Nov; 28(6):306-312. PubMed ID: 34697046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different types, applications and limits of enabling excipients of pharmaceutical dosage forms.
    Palcsó B; Zelkó R
    Drug Discov Today Technol; 2018 Jul; 27():21-39. PubMed ID: 30103860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipid excipients and delivery systems for pharmaceutical development: a regulatory perspective.
    Chen ML
    Adv Drug Deliv Rev; 2008 Mar; 60(6):768-77. PubMed ID: 18077051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eunice Kennedy Shriver National Institute of Child Health and Human Development Pediatrics Formulation Initiative: proceedings from the Second Workshop on Pediatric Formulations.
    Giacoia GP; Taylor-Zapata P; Zajicek A
    Clin Ther; 2012 Nov; 34(11):S1-10. PubMed ID: 23149008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neonatal and pediatric oral drug delivery: Hopes and hurdles.
    Mfoafo KA; Omidian M; Bertol CD; Omidi Y; Omidian H
    Int J Pharm; 2021 Mar; 597():120296. PubMed ID: 33524524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Excipient pharmacokinetics and profiling.
    Loftsson T
    Int J Pharm; 2015 Mar; 480(1-2):48-54. PubMed ID: 25596414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neonatal Formulations: The Need for a Tailored, Knowledge Driven Approach.
    Allegaert K; Cosaert K; van den Anker JN
    Curr Pharm Des; 2015; 21(39):5674-9. PubMed ID: 26323412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incomplete desorption of liquid excipients reduces the in vitro and in vivo performance of self-emulsifying drug delivery systems solidified by adsorption onto an inorganic mesoporous carrier.
    Van Speybroeck M; Williams HD; Nguyen TH; Anby MU; Porter CJ; Augustijns P
    Mol Pharm; 2012 Sep; 9(9):2750-60. PubMed ID: 22870936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies of beneficial interactions between active medicaments and excipients in pharmaceutical formulations.
    Kalinkova GN
    Int J Pharm; 1999 Sep; 187(1):1-15. PubMed ID: 10502611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro evaluation of extemporaneously compounded immediate-release capsules with premixed excipients, based on the biopharmaceutics classification system (BCS) of the drugs.
    Pinheiro VA; Danopoulos P; Demirdjian L; Nogueira RJ; Dubois F
    Int J Pharm Compd; 2013; 17(5):424-31. PubMed ID: 24459788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Challenge of paediatric compounding to solid dosage forms sachets and hard capsules - Finnish perspective.
    Sivén M; Kovanen S; Siirola O; Hepojoki T; Isokirmo S; Laihanen N; Eränen T; Pellinen J; Juppo AM
    J Pharm Pharmacol; 2017 May; 69(5):593-602. PubMed ID: 27704551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Challenges and innovations of delivering medicines to older adults.
    Gnjidic D; Husband A; Todd A
    Adv Drug Deliv Rev; 2018 Oct; 135():97-105. PubMed ID: 30118723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Use of Propolis in Micro/Nanostructured Pharmaceutical Formulations.
    Bruschi ML; de A Pereira RR; de Francisco LM
    Recent Pat Drug Deliv Formul; 2016; 10(2):130-40. PubMed ID: 26715146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microparticles in the Development and Improvement of Pharmaceutical Formulations: An Analysis of In Vitro and In Vivo Studies.
    da Silva RYP; de Menezes DLB; Oliveira VDS; Converti A; de Lima ÁAN
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.